Given the different activated states of PD-L1 and CTLA-4 pathways in tumor tissues, we further investigated the synthesized effect of TumorPD-L1 and TILsCTLA-4 expression on prognosis in patients with ICC. The gene discussed is CD274; the disease is intrahepatic cholangiocarcinoma.